Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Karyopharm Therapeutics Inc
Autolus Limited
AbbVie
Phoenix Children's Hospital
Orca Biosystems, Inc.
Regeneron Pharmaceuticals
Juno Therapeutics, a Subsidiary of Celgene
Novartis
Novartis
Gilead Sciences
Duke University
AVM Biotechnology Inc
Kura Oncology, Inc.
Kura Oncology, Inc.
Janssen Biotech, Inc.
Gilead Sciences
Eli Lilly and Company
BeiGene
Novartis
AbbVie
Alexion Pharmaceuticals, Inc.
Gilead Sciences
Atara Biotherapeutics
Genmab
EQRx International, Inc.
AbbVie
Merck Sharp & Dohme LLC
Novartis
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Gilead Sciences
Jazz Pharmaceuticals
University of California, San Francisco
ADC Therapeutics S.A.
Seagen Inc.
MorphoSys AG
Molecular Templates, Inc.
ERYtech Pharma
Janssen-Cilag Farmaceutica Ltda.
Barbara Ann Karmanos Cancer Institute
Sanofi
Gilead Sciences
BTG International Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie